Patient-reported behavior and problems in using glaucoma medications
- PMID: 16458967
- DOI: 10.1016/j.ophtha.2005.10.034
Patient-reported behavior and problems in using glaucoma medications
Abstract
Objective: The objectives of the current study were to describe the different types of problems patients receiving adjunctive therapy reported having when taking their glaucoma medications and to examine the relationship between patient-reported problems in taking their glaucoma medications and patient adherence.
Design: Cross-sectional survey.
Participants: A survey was distributed to glaucoma patients in 4 geographically distinct ophthalmology practices. We excluded patients using only 1 glaucoma medication. The survey was completed by 324 patients.
Methods: For each patient, average percent adherence to his or her glaucoma medication regimen was calculated. Logistic regression was used to examine how patient characteristics and problems in using glaucoma medications were related to reported adherence.
Main outcome measure: Whether patients were less than 100% adherent in the previous week.
Results: We found that 60% of patients reported 1 or more problems with taking their glaucoma medications. Fourteen percent of patients reported being less than 100% adherent to their glaucoma regimen medications during the previous week. Patients who had difficulty remembering to take their glaucoma medications and those who reported that they had other problems or concerns with their glaucoma medications were significantly less likely to be 100% adherent.
Conclusions: Patient adherence to a glaucoma medication regimen could be improved among patients receiving adjunctive therapy. Ophthalmologists and their clinical colleagues should make sure to discuss the problems and concerns that patients may have in taking their glaucoma medications in an effort to improve adherence.
Similar articles
-
Doctor-patient communication, health-related beliefs, and adherence in glaucoma results from the Glaucoma Adherence and Persistency Study.Ophthalmology. 2008 Aug;115(8):1320-7, 1327.e1-3. doi: 10.1016/j.ophtha.2007.11.023. Epub 2008 Mar 5. Ophthalmology. 2008. PMID: 18321582
-
Intentional and unintentional nonadherence to ocular hypotensive treatment in patients with glaucoma.Ophthalmology. 2010 May;117(5):903-8. doi: 10.1016/j.ophtha.2009.10.038. Epub 2010 Feb 13. Ophthalmology. 2010. PMID: 20153902
-
Effect of selected antihypertensives, antidiabetics, statins and diuretics on adjunctive medical treatment of glaucoma: a population based study.Curr Med Res Opin. 2009 Aug;25(8):1879-88. doi: 10.1185/03007990903035083. Curr Med Res Opin. 2009. PMID: 19530975
-
Patient-centered communication to assess and enhance patient adherence to glaucoma medication.Ophthalmology. 2009 Nov;116(11 Suppl):S37-42. doi: 10.1016/j.ophtha.2009.06.023. Ophthalmology. 2009. PMID: 19837259 Review.
-
A comprehensive perspective on patient adherence to topical glaucoma therapy.Ophthalmology. 2009 Nov;116(11 Suppl):S30-6. doi: 10.1016/j.ophtha.2009.06.024. Ophthalmology. 2009. PMID: 19837258 Review.
Cited by
-
Quality of Life in Glaucoma: A Review of the Literature.Adv Ther. 2016 Jun;33(6):959-81. doi: 10.1007/s12325-016-0333-6. Epub 2016 Apr 30. Adv Ther. 2016. PMID: 27138604 Free PMC article. Review.
-
Novel tactile bottle neck adaptor facilitates eye drop adherence in visually impaired patients.BMJ Open Ophthalmol. 2023 Dec 28;8(1):e001462. doi: 10.1136/bmjophth-2023-001462. BMJ Open Ophthalmol. 2023. PMID: 38154911 Free PMC article. Clinical Trial.
-
Predictors of additional intraocular pressure reduction in patients changed to latanoprost/timolol fixed combination.BMC Ophthalmol. 2010 Mar 26;10:10. doi: 10.1186/1471-2415-10-10. BMC Ophthalmol. 2010. PMID: 20346127 Free PMC article. Clinical Trial.
-
Safety and efficacy of a fixed versus unfixed brinzolamide/timolol combination in Japanese patients with open-angle glaucoma or ocular hypertension.Clin Ophthalmol. 2014 Jan 13;8:219-28. doi: 10.2147/OPTH.S55590. eCollection 2014. Clin Ophthalmol. 2014. PMID: 24531757 Free PMC article.
-
Comparison of the Intraocular Pressure-Lowering Efficacy and Safety of the Brinzolamide/Brimonidine Fixed-Dose Combination versus Concomitant Use of Brinzolamide and Brimonidine for Management of Open-Angle Glaucoma or Ocular Hypertension.Clin Ophthalmol. 2020 Jan 23;14:221-230. doi: 10.2147/OPTH.S231402. eCollection 2020. Clin Ophthalmol. 2020. PMID: 32158181 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical